BioCryst Pharmaceuticals Inc · BCRX.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $514.16M − (Liabilities $633.31M + Equity -$119.15M) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$89.74M
17.5%
-$15.19M
-14.5%
Assets
Receivables
$106.82M
20.8%
$27.75M
35.1%
Assets
Other current assets
$17.38M
3.4%
$3.63M
26.4%
Assets
PPE
$18.99M
3.7%
-$799.00K
-4.0%
Assets
Investments
$61.16M
11.9%
$40.84M
201.0%
Assets
Other
$220.07M
42.8%
-$32.50M
-12.9%
Liabilities + Equity
Accounts payable
$15.83M
3.1%
$4.18M
35.9%
Liabilities + Equity
Long-term debt
$427.23M
83.1%
-$368.69M
-46.3%
Liabilities + Equity
Other liabilities
$190.25M
37.0%
$31.46M
19.8%
Liabilities + Equity
Equity
-$119.15M
-23.2%
$356.78M
75.0%